Moxicylyte metabolic pathway (Homo sapiens)

Revision as of 14:10, 22 May 2021 by Eweitz (Talk | contribs)

(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)

Description

Metabolism pathway of moxicylyte as it is observed in man, dog, cat, and rat.

View approved pathways at the new wikipathways.org.

Marquer C, Bressolle F; ''Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in impotence.''; Fundam Clin Pharmacol, 1998 PubMed Europe PMC Scholia
Vollmer KO, von Hodenberg A; ''Metabolism of thymoxamine. III. Structure elucidation of the metabolites and interspecies comparison.''; Eur J Drug Metab Pharmacokinet, 1985 PubMed Europe PMC Scholia

View all...

Revision	Action	Time	User	Comment
117797	view	14:10, 22 May 2021	Eweitz	Modified title
92289	view	12:39, 19 May 2017	Egonw	Ontology Term : 'xenobiotic metabolic pathway' added !
70547	view	20:39, 10 August 2013	Egonw	Modified description
70546	view	20:37, 10 August 2013	Egonw	Added a second reference for this pathway
70526	view	15:31, 9 August 2013	Egonw	ChemSpider approved my structure submission: 29273477.
70523	view	15:19, 9 August 2013	Egonw	Ontology Term : 'cellular detoxification pathway' added !
70521	view	14:40, 9 August 2013	Egonw	New pathway

View all...

Name	Type	Database reference
DAM-G	Metabolite
DAM-S	Metabolite	14130340 (PubChem-compound)
DAM	Metabolite	28093 (PubChem-compound)
MDAM-G	Metabolite
MDAM-S	Metabolite	29273477 (Chemspider)
MDAM	Metabolite	51678 (PubChem-compound)
Moxisylyte	Metabolite	4260 (PubChem-compound)

No annotated interactions